922 studies found for:    Uterine Diseases: Clinical Trials
Show Display Options
Rank Status Study
21 Recruiting Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer;   Fallopian Cancer;   Peritoneal Cancer
Interventions: Biological: E39 peptide vaccine;   Other: Clinical tracking for disease progression/recurrence
22 Unknown  Efficacy Study of Vaginal Mesh for Prolapse
Conditions: Pelvic Organ Prolapse;   Uterine Prolapse;   Vaginal Prolapse;   Cystocele;   Rectocele
Intervention: Device: synthetic monofilament polypropylene mesh
23 Unknown  Study of Pap Smears From Patients Enrolled on Clinical Trial GOG-171
Conditions: Cervical Cancer;   Precancerous Condition
Interventions: Other: Papanicolaou test;   Other: laboratory biomarker analysis
24 Not yet recruiting Phase II, Open Label, Non-randomized, Trial of BKM120 for Metastatic or Locally Advanced Cervical Cancer
Condition: Treatment for Metastatic or Locally Advanced Cervical Cancer
Intervention: Drug: BKM120
25 Recruiting Folic Acid Clinical Trial for the Prevention of Cervical Cancer
Conditions: Cervical Cancer;   Precancerous Condition
Interventions: Dietary Supplement: folic acid;   Other: placebo
26 Unknown  Efficacy Study of Vaginal Mesh for Anterior Prolapse
Conditions: Vaginal Prolapse;   Uterine Prolapse;   Cystocele;   Pelvic Organ Prolapse
Intervention: Device: synthetic polypropylene mesh
27 Completed A Trial for Patients With Gestational Trophoblastic Disease
Conditions: Trophoblastic Neoplasms;   Uterine Neoplasms;   Hydatidiform Mole;   Choriocarcinoma
Intervention: Drug: Pemetrexed
28 Active, not recruiting Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
Conditions: Extensive Stage Small Cell Lung Cancer;   Hereditary Paraganglioma;   Male Breast Cancer;   Malignant Paraganglioma;   Metastatic Gastrointestinal Carcinoid Tumor;   Metastatic Pheochromocytoma;   Pancreatic Polypeptide Tumor;   Recurrent Breast Cancer;   Recurrent Cervical Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Islet Cell Carcinoma;   Recurrent Neuroendocrine Carcinoma of the Skin;   Recurrent Non-small Cell Lung Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Pheochromocytoma;   Recurrent Prostate Cancer;   Recurrent Renal Cell Cancer;   Recurrent Small Cell Lung Cancer;   Recurrent Uterine Sarcoma;   Regional Gastrointestinal Carcinoid Tumor;   Regional Pheochromocytoma;   Stage III Cervical Cancer;   Stage III Endometrial Carcinoma;   Stage III Neuroendocrine Carcinoma of the Skin;   Stage III Ovarian Epithelial Cancer;   Stage III Ovarian Germ Cell Tumor;   Stage III Prostate Cancer;   Stage III Renal Cell Cancer;   Stage III Uterine Sarcoma;   Stage IIIA Breast Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Breast Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer;   Stage IV Endometrial Carcinoma;   Stage IV Neuroendocrine Carcinoma of the Skin;   Stage IV Non-small Cell Lung Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor;   Stage IV Prostate Cancer;   Stage IV Renal Cell Cancer;   Stage IV Uterine Sarcoma;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer;   Thyroid Gland Medullary Carcinoma
Interventions: Drug: temsirolimus;   Drug: vinorelbine ditartrate
29 Recruiting A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Conditions: Sexual Dysfunctions, Psychological;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Uterine Neoplasms;   Genital Neoplasms, Female
Intervention: Behavioral: GyneGals Support Group
30 Terminated A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer
Condition: Cervical Neoplasms
Interventions: Drug: neoadjuvant chemotherapy + radical hysterectomy;   Procedure: radical hysterectomy
31 Active, not recruiting Concurrent Chemoradiation With Cisplatin Every 3 Week in Advanced Cervical Cancer
Condition: CERVICAL NEOPLASMS
Intervention: Drug: CONCURRENT CHEMORADIATION (CISPLATIN)
32 Completed Acceptability of Less Harmful Alternatives to Cigarettes
Conditions: Bladder Cancer;   Cervical Cancer;   Esophageal Cancer;   Gastric Cancer;   Head and Neck Cancer;   Kidney Cancer;   Leukemia;   Liver Cancer;   Lung Cancer;   Pancreatic Cancer;   Tobacco Use Disorder
Interventions: Behavioral: telephone-based intervention;   Drug: nicotine replacement therapy;   Other: informational intervention;   Other: internet-based intervention;   Other: questionnaire administration
33 Unknown  Economic Evaluation of Three Populational Screening Strategies for Cervical Cancer
Condition: Uterine Cervical Neoplasms
Intervention: Other: Different alternatives to improve the coverage of the populational screening programmes of cervical cancer
34 Completed Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Condition: Pelvic Organ Prolapse
Interventions: Device: TVT;   Other: Sham
35 Enrolling by invitation Randomized Clinical Trial Comparing Conventional Laparoscopic and Robot-Assisted Laparoscopic Hysterectomy
Conditions: Menorrhagia;   Pelvic Pain;   Hysterectomy
Intervention: Procedure: Hysterectomy
36 Completed Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma
Conditions: Leiomyosarcoma;   Uterine Neoplasm
Intervention: Drug: gemcitabine, docetaxel, doxorubicin
37 Recruiting A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia
Condition: Cervical Dysplasia
Intervention: Drug: Nelfinavir
38 Unknown  A Trial Comparing Intensity Modulated Radiation Therapy (IMRT) With Conventional Radiation Therapy in Stage IIB Carcinoma Cervix
Condition: Cancer of Cervix
Intervention: Radiation: IMRT
39 Completed Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia
Conditions: Cervical Cancer;   Precancerous Condition
Intervention: Biological: pNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine
40 Unknown  Controlled Clinical Trial of Supplemental Oxygen for the Prevention of Post-Cesarean Infectious Morbidity
Conditions: Cesarean Section;   Surgical Wound Infection;   Endometritis
Interventions: Other: 80% inhaled oxygen via non-rebreather mask;   Other: 30% inhaled oxygen via nasal cannula

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years